In The News
Editorial: Research community ready for Open Source Drug Discovery
Editorial: Research community ready for Open Source Drug Discovery In an Editorial to the Canadian Science Policy Centre, Drs. Aled Edwards and Aidan Hollis describe the need for Open Source Drug Discovery [...]
OICR’s Cancer Therapeutics Innovation Pipeline initiative funds M4K’s ALK2 program for DIPG as part of the inaugural set of projects
OICR's Cancer Therapeutics Innovation Pipeline initiative funds M4K's ALK2 program for DIPG as part of the inaugural set of projects The Ontario Institute for Cancer Research (OICR) announced its Cancer Therapeutics [...]
U of T News covers M4K Pharma’s innovative business model for drug discovery
Making medicine, not money: How one U of T researcher's startup is rethinking Big Pharma's business model M4K Pharma's first target is a rare childhood brain cancer that's just as [...]